Ρεματοειδής Αρθρίτιδα εργοστάσιο, αγοράστε καλής ποιότητας Ρεματοειδής Αρθρίτιδα προϊόντα από την Κίνα

N-μεθυλο-N-((3R,4R) -4-μεθυλοπιπεριδίνη-3-ιλ) -7H-πυρρόλο[2,3-δ]πυριμιδίνη-4-αμίνη (477600-74-1)

This compound is mainly used for synthesis of Tofacitinib as intermediate B2. Product Name: N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS No.: 477600-74-1 Assay: 98% End Use: Tofacitinib Molecular Formula: C13H19N5 Molecular Weight: 245.33 Shelf Life: 2 Years Package: 25kg/drum

Τοφασιτινίμπη Citrate (540737-29- 9)

Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Product Name: Tofacitinib Citrate CAS No.: 540737-29-9 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C22H28N6O8 Molecular Weight: 504.50 Shelf Life: 2 Years Package: 25kg/drum

4-Χλωρο-7H-πυρρόλο[2,3-d]πυριμιδίνη (3680-69-1)

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine is an important intermediate in organic synthesis. In the synthesis of Tofacitinib, it is used as intermediate. Product Name: 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 3680-69-1 Assay: 98% End Use: Tofacitinib Molecular Formula: C6H4ClN3 Molecular Weight: 153.57 Shelf Life: 2 Years Package: 25kg/drum

(3R,4R)-1-βενzyl-N,4-dimethylpiperidin-3-amine διυδροχλωριούχο (1062580-52-2)

(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride can be used as organic synthesis intermediates and pharmaceutical intermediates, for instance intermediate A for Tofacitinib. Product Name: (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS No.: 1062580-52-2 Assay: 98% End Use: Tofacitinib Molecular Formula: C14H23ClN2 Molecular Weight: 254.8 Shelf Life: 2 Years Package: 25kg/drum

N-((3R,4R)-1-βενζυλο-4-μεθυλοπιπεριδίνη-3-ιλ) -N-μεθυλο-7-τοσίλο-7H-πυρρόλο[2,3-d]πυριμιδίνη-4-αμίνη (923036-30-0)

This compound is mainly used for synthesis of Tofacitinib as intermediate. Product Name: N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS No.: 923036-30-0 Assay: 98% End Use: Tofacitinib Molecular Formula: C27H31N5O2S Molecular Weight: 489.64 Shelf Life: 2 Years Package: 25kg/drum

Ετρασιμόδη (1206123-37- 6)

Etrasimod is a novel oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment of adult patients with moderately to severely active ulcerative colitis. It can partially reversibly block the outflow of lymphocytes and reduce the number of lymphocytes in the peripheral blood, thereby reducing the migration of lymphocytes into the intestine and exerting a therapeutic effect. Product Name: Etrasimod CAS No.: 1206123-37-6 Assay: 99% Specification: CP, EP,

Εθυλο2-(7-υδροξυ-1,2,3,4-τετραϋδροκυκλοπέντα[β]ινδολ-3-υλο) οξικό (1206124-13-1)

Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate is an intermediate of Etrasimod. Product Name: Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate CAS No.: 1206124-13-1 Assay: 98% End Use: Etrasimod Molecular Formula: C15H17NO3 Molecular Weight: 259.3 Shelf Life: 2 Years Package: 25kg/drum

4-Χλωρομεθυλο-1-κυκλοεντυλο-2-τριφθορομεθυλοβενζόλιο (957208-65-0)

4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene is an intermediate of Etrasimod. Product Name: 4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene CAS No.: 957208-65-0 Assay: 98% End Use: Etrasimod Molecular Formula: C13H14ClF3 Molecular Weight: 262.7 Shelf Life: 2 Years Package: 25kg/drum

1-(1-εθοξυαιθυλ) -4-(4,4,5,5-τετραμεθυλο-1,3,2-διοξαβορολάν-2-ιλ) - 1H-πυραζόλη (1029716-44-6)

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is an intermediate for synthesis of Baricitinib, also for other compounds. Product Name: 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole CAS No.: 1029716-44-6 Assay: 98% End Use: Baricitinib Molecular Formula: C13H23BN2O3 Molecular Weight: 266.15 Shelf Life: 2 Years Package: 25kg/drum

2-(1-(αιθυλσουλφονύλιο) αζετιδίνη-3-υλιδίνη) ακετονιτρίλη (1187595-85-2)

Baricitinib intermediate 2 is an intermediate for synthesis of Baricitinib. Product Name: 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitril CAS No.: 1187595-85-2 Assay: 98% End Use: Baricitinib Molecular Formula: C7H10N2O2S Molecular Weight: 186.23 Shelf Life: 2 Years Package: 25kg/drum

(1h-πυραζόλη-4-υλ)-7-((2-(τριμεθυλοσιλλ) αιθοξυ) μεθυλ)-7h-πυρρόλο[2,3-d]πυριμιδίνη (941685-27-4)

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is an intermediate for synthesis of Baricitinib. Product Name: (1h-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7h-pyrrolo[2,3-d]pyrimidine CAS No.: 941685-27-4 Assay: 98% End Use: Baricitinib Molecular Formula: C15H21N5O Molecular Weight: 315.45 Shelf Life: 2 Years Package: 25kg/drum

Βαρισιτινίμπη Φωσφορικό (1187595-84-1)

Baricitinib is a JAK1 and JAK2 inhibitor and have been used as a promising treatment for rheumatoid arthritis. Product Name: Baricitinib Phosphate CAS No.: 1187595-84-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C16H20N7O6PS Molecular Weight: 469.41 Shelf Life: 2 Years Package: 25kg/drum

N-(4-(2-αμινοακετυλ) -5-μεθοξυ-2-φαινοξυφαινύλιο) μεθανυλουφοναμίδη υδροχλωρίδιο 149436-41-9

N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide is an intermediate of Ellamod. Product Name: N-(4-(2-Aminoacetyl)-5-Methoxy-2-Phenoxyphenyl) MethanesulfonamideHydrochloride CAS No.: 149436-41-9 Assay: 98% End Use: Ellamod Molecular Formula: C16H19ClN2O5S Molecular Weight: 386.85 Shelf Life: 2 Years Package: 25kg/drum; 1kg/bag; 100g/bag

N- ((5-Μεθοξυ-2-φαινοξυφαινύλη) μεθανασουλφοναμίδη 123664-84-6

N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide is an intermediate of Ellamod. Product Name: N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide CAS No.: 123664-84-6 Assay: 98% End Use: Ellamod Molecular Formula: C14H15NO4S Molecular Weight: 293.34 Shelf Life: 2 Years Package: 25kg/drum; 1kg/bag; 100g/bag